Form 4: AMN Healthcare Director Receives Restricted Stock Units

Teri G. Fontenot, a Director at AMN Healthcare Services Inc., was granted 8,304 Restricted Stock Units (RSUs) on May 1, 2026, with vesting scheduled for May 1, 2027, or the 2027 Annual Meeting of Shareholders.

Summary

• Teri G. Fontenot, a Director of AMN Healthcare Services Inc., received a grant of 8,304 Restricted Stock Units (RSUs) on May 1, 2026.
• These RSUs are part of the AMN Healthcare 2025 Equity Plan.
• Each RSU represents a contingent right to receive one share of AMN Common Stock.
• The RSUs will vest on the earlier of the one-year anniversary of the grant date (May 1, 2027) or the date of the Company's Annual Meeting of Shareholders in 2027.
• The reporting owner has elected for the RSUs to settle on the date of separation from service with the Company.
• The filing indicates no purchase or sale price for these RSUs, with a value of $0 at the time of grant.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. It reports a routine equity grant to a director, which is standard practice and does not inherently signal positive or negative performance.

Positives

• Grant of equity awards to a director, indicating alignment of management and shareholder interests.
• The RSUs are granted under an existing equity plan, suggesting a structured approach to compensation.
• Vesting schedule provides a retention incentive for the director.

Negatives

• No financial performance metrics are associated with this grant, making it difficult to assess its direct impact on company performance.
• The filing is a Form 4, which reports changes in beneficial ownership and does not contain operational or financial results.

Risks

• Potential dilution of existing shareholder equity if a large number of RSUs vest and are settled.
• The value of the RSUs is tied to the future stock price of AMN Healthcare, which is subject to market volatility and company performance.

Future Outlook

The RSUs are set to vest on or before the company's 2027 Annual Meeting of Shareholders, with settlement occurring upon the director's separation from service. The future value of these units is contingent on the company's stock performance.

Management Comments

• The filing is a standard SEC Form 4 reporting a transaction by an insider and does not contain direct management comments or quotes.
• The explanation of responses clarifies the terms of the RSU grant, including the vesting conditions and settlement terms.

Industry Context

StockSavvy.ai notes that equity grants to directors are a common practice in the healthcare services industry to incentivize long-term performance and align executive interests with shareholders. The structure of this grant, with a one-year vesting period and settlement upon separation, is typical for director compensation packages.

Stakeholder Impact

• Shareholders: Potential for slight equity dilution upon vesting and settlement of RSUs. The grant aims to align director interests with long-term shareholder value.
• Employees: No direct impact mentioned.
• Management: Teri G. Fontenot's compensation is enhanced by this equity grant.
• Creditors: No direct impact mentioned.

Next Steps

• Vesting of the 8,304 RSUs on or before the 2027 Annual Meeting of Shareholders.
• Settlement of the RSUs upon Teri G. Fontenot's separation from service with AMN Healthcare Services, Inc.
• Future filings (Form 4) will report any subsequent transactions by Teri G. Fontenot.

Key Dates

Keywords

AMN Healthcare, Form 4, Restricted Stock Units, RSU, Equity Grant, Director Compensation, Securities Exchange Act, Beneficial Ownership